Arrowhead Pharmaceuticals, a California-based pharmaceutical company that makes genetic treatments for hard-to-treat diseases, has announced plans to build a $250 million manufacturing campus in the Verona Technology Park, just outside of Madison, Wisconsin.
The expansion will bring about 250 jobs to the region. Arrowhead Pharmaceuticals has a research and development location in Madison, Wisconsin, as well as locations in San Diego and Pasadena, California. Arrowhead will join pharmaceutical giant MiliporeSigma in the technology park.
“The pharmaceutical, medical equipment industry in Wisconsin continues to grow,” said Coleman Peiffer, Alliant Energy’s senior business attraction manager. “The region’s talent and education system are ideal to support bio-health, high-tech companies.”
According to the Wisconsin Economic Development Corporation, Wisconsin exported $2 billion in medical and scientific instruments in 2020. Nearly 1,700 bio-health patents were awarded to Wisconsin entities from 2015-2019.
Learn more about how we work with the diverse and fast-growing bioscience sector.